Hot flashes are widely considered a menopause symptom worth treating. Now, two new studies show they may be even more reason to seek medical attention: The sudden sensations of heat can be a risk ...

Doctors and the CDC recommend everyone over 6 months get the new COVID-19 vaccine as fears of complications ease.

Driving the technology forward are advances in materials science and AI, plus patient benefits like shorter recovery times and less pain.

An estimated 18 million adults in the U.S. have had long COVID, and half of them are still dealing with the condition, new national survey data shows.

Non-menstruating women were more likely to experience unexpected vaginal bleeding after receiving COVID-19 vaccinations, according to a new study.

The CDC reports that anyone who is unvaccinated is at risk for severe COVID. Other factors include: Having underlying medical conditions including asthma and other respiratory conditions, diabetes, ...

People with long COVID have specific biomarkers in their blood, a study published Monday in Nature said. The findings may be a step toward creating blood tests to positively identify people with long ...

The antiviral COVID medication molnupiravir made by Merck can cause mutations in the coronavirus that occasionally spread to other people, according to a study published in the online journal Nature.

It was just a routine checkup -- or so she thought. One woman’s syphilis scare mirrors thousands of others amid a syphilis outbreak in the U.S., with Houston at the epicenter.

Sept. 19, 2023 – A silent disorder is rising among older people worldwide, as millions unknowingly grapple with glaucoma – an eye condition that can cause irreversible blindness but shows no ...

Medication errors among children who take drugs to treat attention deficit hyperactivity disorder (ADHD) reported to U.S. poison control centers increased by nearly 300% over a 22-year period, a new ...

Sept. 13, 2023 -- America's most popular oral nasal decongestant, phenylephrine, is not effective and no better than a placebo, an FDA panel said Tuesday. The unanimous vote of the ...